Literature DB >> 20950081

Stereotactic depth electrode investigation of the insula in the evaluation of medically intractable epilepsy.

Atman Desai1, Barbara C Jobst, Vijay M Thadani, Krzysztof A Bujarski, Karen Gilbert, Terrance M Darcey, David W Roberts.   

Abstract

OBJECT: The authors describe their experience with stereotactic implantation of insular depth electrodes in patients with medically intractable epilepsy.
METHODS: Between 2001 and 2009, 20 patients with epilepsy and suspected insular involvement during seizures underwent intracranial electrode array implantation at the authors' institution. All patients had either 1 or 2 insular depth electrodes placed as part of an intracranial array.
RESULTS: A total of 29 insular depth electrodes were placed using a frontal oblique trajectory. Eleven patients had a single insular electrode placed and 8 patients had 2 insular electrodes placed unilaterally. One patient had bilateral insular electrodes implanted. Postoperative imaging demonstrated satisfactory placement in all but 1 instance, and there was no associated morbidity or mortality. Fourteen patients underwent a subsequent resection, involving the frontal lobe (9 patients), temporal lobe (4), or frontotemporal lobes (1), and of these, 11 currently have Engel Class I outcome. Two patients (10%) had seizures originating within the insula and another 5 patients (25%) demonstrated early specific insular involvement. Neither patient with an insular seizure focus went on to resection. All 5 of the patients with early specific insular involvement underwent an insula-sparing resective procedure with Engel Class I outcome in all cases.
CONCLUSIONS: Stereotactic placement of insular electrodes via a frontal oblique approach is a safe and efficient technique for investigating insular involvement in medically intractable epilepsy. The information obtained from insular recording can be valuable for appreciating the degree of insular contribution to seizures, allowing localization to the insula or clearer implication of other sites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950081     DOI: 10.3171/2010.9.JNS091803

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Intracranial electrodes in the presurgical evaluation of epilepsy.

Authors:  Jinxian Yuan; Yangmei Chen; Edouard Hirsch
Journal:  Neurol Sci       Date:  2012-03-30       Impact factor: 3.307

Review 2.  Stereoelectroencephalography: Indication and Efficacy.

Authors:  Koji Iida; Hiroshi Otsubo
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-06-20       Impact factor: 1.742

3.  The Insula and Its Epilepsies.

Authors:  Barbara C Jobst; Jorge Gonzalez-Martinez; Jean Isnard; Philippe Kahane; Nuria Lacuey; Samden D Lahtoo; Dang K Nguyen; Chengyuan Wu; Fred Lado
Journal:  Epilepsy Curr       Date:  2019-01-31       Impact factor: 7.500

4.  Somatosensory and pharyngolaryngeal auras in temporal lobe epilepsy surgeries.

Authors:  Alexander G Weil; Werner Surbeck; Ralph Rahme; Alain Bouthillier; Adil Harroud; Dang Khoa Nguyen
Journal:  ISRN Neurol       Date:  2013-06-03

5.  Rapid and efficient localization of depth electrodes and cortical labeling using free and open source medical software in epilepsy surgery candidates.

Authors:  Juan Pablo Princich; Demian Wassermann; Facundo Latini; Silvia Oddo; Alejandro Omar Blenkmann; Gustavo Seifer; Silvia Kochen
Journal:  Front Neurosci       Date:  2013-12-31       Impact factor: 4.677

6.  Modulation of Frontal Oscillatory Power during Blink Suppression in Children: Effects of Premonitory Urge and Reward.

Authors:  Makoto Miyakoshi; Joseph Jurgiel; Andrea Dillon; Susanna Chang; John Piacentini; Scott Makeig; Sandra K Loo
Journal:  Cereb Cortex Commun       Date:  2020-08-06

7.  Neurosurgical robot-assistant stereoelectroencephalography system: Operability and accuracy.

Authors:  Di Zhang; Xuehua Cui; Jie Zheng; Shunyao Zhang; Meng Wang; Wenpeng Lu; Linxia Sang; Wenling Li
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.